Clinical context
Cataract surgery outcomes are not defined by best-corrected visual acuity alone. Refractive accuracy, vision at different distances, spectacle dependence, contrast sensitivity, dysphotopsia and procedural safety all matter. Corneal and macular status, capsular support, cataract density and IOL calculation also shape the final result. A statistically convincing average therefore still has to be interpreted against the characteristics of an individual eye.
What was studied
This retrospective comparison tested whether IOL formula selection by biometric profile improves prediction. It included 626 eyes after uncomplicated in-the-bag cataract surgery, divided into a 351-eye derivation set and an independent 275-eye validation set. Combinations of keratometry, anterior chamber depth and axial length created 640 possible subgroups. For represented subgroups, the lowest-MAE formula was selected; empty combinations used a median-based assignment.
How the evidence was produced
A cohort study describes how outcomes are associated with an exposure or treatment in an observed clinical population. This design is useful for routine practice, uncommon events and longer follow-up, but it remains vulnerable to confounding by indication, baseline risk differences and missing data. An association should not automatically be interpreted as a causal effect.
How to interpret the result
The study supports anatomy-based selection rather than one universal winner. Clinically, it can provide an additional estimate and flag discordant formulas. It does not replace constant optimization, reliable biometry or local outcome auditing. Applicability also depends on whether a patient belongs to a well-represented rather than sparse subgroup.
The result should be understood as an estimate for the population studied, not a promise of an individual outcome. Statistical and clinical significance, absolute and relative effects, and prespecified and exploratory analyses should be distinguished. When several endpoints or subgroups are reported, the prespecified primary endpoint for which the study was designed usually provides the most reliable inference.
Clinical applicability
This evidence is most useful as a basis for preoperative discussion and surgical planning. It helps identify which outcomes should be measured and which trade-offs should be explained to patients. The average effect should not be generalized to every IOL, technique or patient without checking eligibility criteria, surgeon experience, biometry, ocular comorbidity and duration of follow-up.
Limitations
The design was retrospective, and 640 combinations greatly exceeded 351 derivation eyes, leaving many cells empty or sparse. Validation used separate eyes but came from two South Korean institutions and may share equipment, population and technique. Verify IOL models, formula versions and constants, subgroup sizes, frequency of median assignment, error centering, outliers, misses over 1 D, funding and external validation in the full paper.
Beyond the limitations acknowledged by the authors, confidence is affected by sample size, follow-up duration, missing data, choice of comparator and relevance of the outcomes to routine care. Uncommon complications may remain undetected even in a well-conducted study. External validity is reduced when participants, equipment or investigator expertise differ substantially from everyday settings.
What to verify in the source
In the full paper, verify the protocol, eligibility criteria, baseline group characteristics, primary endpoint definition, confidence intervals, adverse events and losses to follow-up. Funding, conflicts of interest, trial registration and consistency between the published analysis and the original plan deserve separate attention. The DOI or source link below provides access to the primary publication for this check.